|
DIAPH3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.051200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.328000E-01 |
| Normal-vs-Stage2 |
6.459400E-01 |
| Normal-vs-Stage3 |
1.978760E-01 |
| Normal-vs-Stage4 |
6.537200E-01 |
| Stage1-vs-Stage2 |
6.219800E-01 |
| Stage1-vs-Stage3 |
8.127600E-01 |
| Stage1-vs-Stage4 |
6.977800E-02 |
| Stage2-vs-Stage3 |
5.284000E-01 |
| Stage2-vs-Stage4 |
3.804000E-01 |
| Stage3-vs-Stage4 |
7.394100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.372400E-01 |
| Normal-vs-AfricanAmerican |
3.357200E-01 |
| Normal-vs-Asian |
8.539200E-01 |
| Caucasian-vs-AfricanAmerican |
6.680000E-01 |
| Caucasian-vs-Asian |
5.666200E-01 |
| AfricanAmerican-vs-Asian |
4.882000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.833800E-01 |
| Normal-vs-Female |
7.814500E-02 |
| Male-vs-Female |
1.332110E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.515200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.586200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.527200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.172100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.911610E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.221190E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.078400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.461600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.039700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.341400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.232800E-01 |
| Normal-vs-Grade 2 |
3.036800E-01 |
| Normal-vs-Grade 3 |
2.105600E-01 |
| Normal-vs-Grade 4 |
8.509600E-01 |
| Grade 1-vs-Grade 2 |
7.852800E-01 |
| Grade 1-vs-Grade 3 |
9.177800E-01 |
| Grade 1-vs-Grade 4 |
4.859600E-01 |
| Grade 2-vs-Grade 3 |
6.523200E-01 |
| Grade 2-vs-Grade 4 |
2.519400E-01 |
| Grade 3-vs-Grade 4 |
1.526220E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.732000E-02 |
| Normal-vs-ccB subtype |
5.932200E-01 |
| ccA subtype-vs-ccB subtype |
2.0665999999947E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.593200E-01 |
| Normal-vs-N1 |
9.652500E-02 |
| N0-vs-N1 |
4.462100E-02 |
|
|
